| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T735 |
0-79 |
Sentence |
denotes |
Fu, 202065Chengdu Public Health Clinical Medical Center (Chengdu)SichuanDates: |
| T736 |
80-113 |
Sentence |
denotes |
1/1/2020-2/20/2020Last follow-up: |
| T737 |
114-139 |
Sentence |
denotes |
2/29/2020 n = 52Survival: |
| T738 |
140-198 |
Sentence |
denotes |
100% (excluded patients who were not discharged)Inclusion: |
| T739 |
199-244 |
Sentence |
denotes |
Inpatients with COVID-19 confirmed by RT-PCR. |
| T740 |
245-299 |
Sentence |
denotes |
Excluded patients who died or were not discharged.Age: |
| T741 |
300-331 |
Sentence |
denotes |
M 44.5 y (IQR, 33.0–56.5 y)Sex: |
| T742 |
332-474 |
Sentence |
denotes |
46% femalesGI/liver comorbidities: NRDisease severity: common coronavirus pneumonia type 73.1%, severe 19.2%, critically severe 7.7% Diarrhea: |
| T743 |
475-514 |
Sentence |
denotes |
13.5% (7/52)Present on admissionNausea: |
| T744 |
515-950 |
Sentence |
denotes |
1.9 % (1/52)Present on admissionVomiting and abdominal pain: NR AST M 27 (IQR, 21.2–34.0)ALT M 24 (IQR, 15.3–49)Bilirubin 85 patients M 67.3 (IQR, 63.5–71.4)Patients with laboratory results on admission and discharge n = 23ASTOn presentation M 27 (IQR, 23–35)After discharge M 25 (IQR, 19–39)ALTOn presentation M 25 (IQR, 14–41)After discharge M 31 (IQR, 15–41)BilirubinOn presentation M 66 (IQR, 60–72)After discharge M 65 (IQR, 60–69 |
